Aging, inflammation, stem cells, and bone healing
- PMID: 27006071
- PMCID: PMC4804630
- DOI: 10.1186/s13287-016-0300-9
Aging, inflammation, stem cells, and bone healing
Abstract
Complex interactions among cells of the monocyte-macrophage-osteoclast lineage and the mesenchymal stem cell-osteoblast lineage play a major role in the pathophysiology of bone healing. Whereas the former lineage directs inflammatory events and bone resorption, the latter represents a source of cells for bone regeneration and immune modulation. Both of these lineages are affected by increasing age, which is associated with higher baseline levels of inflammatory mediators, and a significant reduction in osteogenic capabilities. Given the above, fracture healing, osteoporosis, and other related events in the elderly present numerous challenges, which potentially could be aided by new therapeutic approaches to modulate both inflammation and bone regeneration.
Figures
References
-
- UScensus. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau, Washington. 2010. http://www.census.gov/prod/cen2010/briefs/c2010br-09.pdf. Accessed 29 July 2015.
-
- UScensus. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau, Washington. 2015. http://www.census.gov/content/dam/Census/library/publications/2015/demo/... Accessed 29 July 2015.
-
- Office of the Surgeon General (US). Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville (MD): Office of the Surgeon General (US); 2004. 5, The Burden of Bone Disease. Available from: http://www.ncbi.nlm.nih.gov/books/NBK45502/. Accessed 29 July 2015. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
